Search

everythinglearnresearchcommunity

for

Search:↓

Higher antigliadin antibody levels are linked to alopecia areata severity.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia areata involves immune response and gene changes affecting hair loss.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Two mouse mutations cause similar hair loss despite different skin changes.